A model for identifying HERG K+ channel blockers
- 1 May 2004
- journal article
- Published by Elsevier in Bioorganic & Medicinal Chemistry
- Vol. 12 (9) , 2307-2315
- https://doi.org/10.1016/j.bmc.2004.02.003
Abstract
No abstract availableKeywords
This publication has 42 references indexed in Scilit:
- A Novel Mutation (T65P) in the PAS Domain of the Human Potassium Channel HERG Results in the Long QT Syndrome by Trafficking DeficiencyJournal of Biological Chemistry, 2002
- Interaction with GM130 during HERG Ion Channel TraffickingJournal of Biological Chemistry, 2002
- Toward a Pharmacophore for Drugs Inducing the Long QT Syndrome: Insights from a CoMFA Study of HERG K+ Channel BlockersJournal of Medicinal Chemistry, 2002
- Three-Dimensional Quantitative Structure-Activity Relationship for Inhibition of Human Ether-a-Go-Go-Related Gene Potassium ChannelThe Journal of Pharmacology and Experimental Therapeutics, 2002
- Safety of Non-Antiarrhythmic Drugs that Prolong the QT Interval or Induce Torsade de PointesDrug Safety, 2002
- Long QT syndromes and torsade de pointesThe Lancet, 1999
- QT interval prolongation by non-cardiovascular drugs: issues and solutions for novel drug developmentPharmaceutical Science & Technology Today, 1999
- Molecular Genetic Insights into Cardiovascular DiseaseScience, 1996
- HERG, a Human Inward Rectifier in the Voltage-Gated Potassium Channel FamilyScience, 1995
- A mechanistic link between an inherited and an acquird cardiac arrthytmia: HERG encodes the IKr potassium channelCell, 1995